These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 25797266

  • 21. Rosmarinic acid potentiates ATRA-induced macrophage differentiation in acute promyelocytic leukemia NB4 cells.
    Heo SK, Noh EK, Yoon DJ, Jo JC, Koh S, Baek JH, Park JH, Min YJ, Kim H.
    Eur J Pharmacol; 2015 Jan 15; 747():36-44. PubMed ID: 25481858
    [Abstract] [Full Text] [Related]

  • 22. Metformin induces differentiation in acute promyelocytic leukemia by activating the MEK/ERK signaling pathway.
    Huai L, Wang C, Zhang C, Li Q, Chen Y, Jia Y, Li Y, Xing H, Tian Z, Rao Q, Wang M, Wang J.
    Biochem Biophys Res Commun; 2012 Jun 08; 422(3):398-404. PubMed ID: 22575507
    [Abstract] [Full Text] [Related]

  • 23. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N, Ishii Y, Matsuda A, Honma Y.
    Cancer Res; 2001 Jan 01; 61(1):178-85. PubMed ID: 11196157
    [Abstract] [Full Text] [Related]

  • 24. Tetrandrine sensitizes nasopharyngeal carcinoma cells to irradiation by inducing autophagy and inhibiting MEK/ERK pathway.
    Wang J, Yao Z, Lai X, Bao H, Li Y, Li S, Chang L, Zhang G.
    Cancer Med; 2020 Oct 01; 9(19):7268-7278. PubMed ID: 32780562
    [Abstract] [Full Text] [Related]

  • 25. The cleavage product deltaPML-RARalpha contributes to all-trans retinoic acid-mediated differentiation in acute promyelocytic leukemia cells.
    Jing Y, Xia L, Lu M, Waxman S.
    Oncogene; 2003 Jun 26; 22(26):4083-91. PubMed ID: 12821942
    [Abstract] [Full Text] [Related]

  • 26. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
    Riccioni R, Saulle E, Militi S, Sposi NM, Gualtiero M, Mauro N, Mancini M, Diverio D, Lo Coco F, Peschle C, Testa U.
    Leukemia; 2003 Jan 26; 17(1):98-113. PubMed ID: 12529666
    [Abstract] [Full Text] [Related]

  • 27. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
    Rego EM, He LZ, Warrell RP, Wang ZG, Pandolfi PP.
    Proc Natl Acad Sci U S A; 2000 Aug 29; 97(18):10173-8. PubMed ID: 10954752
    [Abstract] [Full Text] [Related]

  • 28. Benzodithiophenes induce differentiation and apoptosis in human leukemia cells.
    Jing Y, Hellinger N, Xia L, Monks A, Sausville EA, Zelent A, Waxman S.
    Cancer Res; 2005 Sep 01; 65(17):7847-55. PubMed ID: 16140954
    [Abstract] [Full Text] [Related]

  • 29. Berbamine selectively induces apoptosis of human acute promyelocytic leukemia cells via survivin-mediated pathway.
    Zhao XY, He ZW, Wu D, Xu RZ.
    Chin Med J (Engl); 2007 May 05; 120(9):802-6. PubMed ID: 17531122
    [Abstract] [Full Text] [Related]

  • 30. A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cells.
    Song G, Shi L, Guo Y, Yu L, Wang L, Zhang X, Li L, Han Y, Ren X, Guo Q, Bi K, Jiang G.
    Oncotarget; 2016 Jan 19; 7(3):3144-57. PubMed ID: 26673819
    [Abstract] [Full Text] [Related]

  • 31. PML/RARalpha fusion protein mediates the unique sensitivity to arsenic cytotoxicity in acute promyelocytic leukemia cells: Mechanisms involve the impairment of cAMP signaling and the aberrant regulation of NADPH oxidase.
    Li L, Wang J, Ye RD, Shi G, Jin H, Tang X, Yi J.
    J Cell Physiol; 2008 Nov 19; 217(2):486-93. PubMed ID: 18636556
    [Abstract] [Full Text] [Related]

  • 32. Tetrandrine enhances antitumor effects of the histone deacetylase inhibitor MS-275 in human cancer in a Bax- and p53-dependent manner.
    Li H, Xu X, Zhang Y, Tang X, Li W.
    Eur J Pharmacol; 2020 Dec 05; 888():173575. PubMed ID: 32950498
    [Abstract] [Full Text] [Related]

  • 33. Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RARα and PLZF-RARα-Driven Leukemia.
    Coltella N, Valsecchi R, Ponente M, Ponzoni M, Bernardi R.
    Clin Cancer Res; 2015 Aug 15; 21(16):3685-94. PubMed ID: 25931453
    [Abstract] [Full Text] [Related]

  • 34. Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy.
    Liu T, Liu X, Li W.
    Oncotarget; 2016 Jun 28; 7(26):40800-40815. PubMed ID: 27027348
    [Abstract] [Full Text] [Related]

  • 35. WEB-2086 and WEB-2170 trigger apoptosis in both ATRA-sensitive and -resistant promyelocytic leukemia cells and greatly enhance ATRA differentiation potential.
    Laurenzana A, Cellai C, Vannucchi AM, Pancrazzi A, Romanelli MN, Paoletti F.
    Leukemia; 2005 Mar 28; 19(3):390-5. PubMed ID: 15674364
    [Abstract] [Full Text] [Related]

  • 36. Auranofin induces apoptosis and when combined with retinoic acid enhances differentiation of acute promyelocytic leukaemia cells in vitro.
    Kim IS, Jin JY, Lee IH, Park SJ.
    Br J Pharmacol; 2004 Jun 28; 142(4):749-55. PubMed ID: 15159275
    [Abstract] [Full Text] [Related]

  • 37. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
    Naeem M, Harrison K, Barton K, Nand S, Alkan S.
    Eur J Haematol; 2006 Feb 28; 76(2):164-6. PubMed ID: 16405439
    [Abstract] [Full Text] [Related]

  • 38. Tamoxifen enhances the differentiation-inducing and growth-inhibitory effects of all-trans retinoic acid in acute promyelocytic leukemia cells.
    Adachi K, Honma Y, Miyake T, Kawakami K, Takahashi T, Suzumiya J.
    Int J Oncol; 2016 Mar 28; 48(3):1095-102. PubMed ID: 26797574
    [Abstract] [Full Text] [Related]

  • 39. Histone modifications patterns in tissues and tumours from acute promyelocytic leukemia xenograft model in response to combined epigenetic therapy.
    Valiulienė G, Treigytė G, Savickienė J, Matuzevičius D, Alksnė M, Jarašienė-Burinskaja R, Bukelskienė V, Navakauskas D, Navakauskienė R.
    Biomed Pharmacother; 2016 Apr 28; 79():62-70. PubMed ID: 27044813
    [Abstract] [Full Text] [Related]

  • 40. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.
    Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R, Naoe T.
    Cancer Res; 1996 Jul 01; 56(13):2945-8. PubMed ID: 8674046
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.